MarketPeel
Insider Trading Intelligence
Pricing
…
DR

David Raben

BCAX
CHIEF MEDICAL OFFICER · BICARA THERAPEUTICS INC. · CIK 0002034679
FILING MIX · LIFETIME37%/63%
BUYS
10
SELLS
17
TOTAL VALUE
$1.45M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
55,286
AVG SELL PX
$18.95
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 21 pending
Forward-return performance of every backtestable P/S trade by David Raben, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+37.50%+1.25%+0.06%+1.19%+2.28%—
14d8+25.00%+2.54%+0.77%+1.77%+0.22%—
30d8+62.50%+1.68%+1.23%+1.01%-8.72%—
60d8+37.50%+6.28%+3.22%+1.66%+1.59%—
90d8(1 pending)+57.14%+2.18%+4.06%-7.47%-12.25%—
180d8(4 pending)+0.00%+16.58%-1.78%+18.37%+18.37%—
1y8(8 pending)——————
2y8(8 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BCAX · 55,286 shares · as of Apr 27, 2026
032,21864,43596,653128,8702026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2026
2026
FLOW · 10 buys / 17 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
5,500$3.79$20.8K60,786Apr 27, 2026Apr 28, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
5,500——41,913Apr 27, 2026Apr 28, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
5,500$22.88$125.8K55,286Apr 27, 2026Apr 28, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
5,500$3.79$20.8K60,786Mar 25, 2026Mar 26, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
5,500——47,413Mar 25, 2026Mar 26, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
5,500$18.95$104.2K55,286Mar 25, 2026Mar 26, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
16,300$18.52$301.9K55,286Mar 4, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
16,300$3.79$61.8K71,586Mar 4, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
16,300——52,913Mar 4, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
200$3.79$75855,486Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
200——69,213Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
200$18.45$3.7K55,286Mar 3, 2026Mar 5, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
100,000——100,000Feb 2, 2026Feb 4, 2026 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
19,789——98,987Dec 26, 2025Dec 29, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
19,789$3.79$75.0K55,286Dec 26, 2025Dec 29, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
906$18.84$17.1K35,497Nov 25, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
4,594——118,776Nov 25, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
4,594$3.79$17.4K40,091Nov 25, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
906$3.79$3.4K36,403Nov 25, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
4,594$18.84$86.6K35,497Nov 25, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
906——69,413Nov 25, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
5,500$18.45$101.5K35,497Nov 24, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
5,500——123,370Nov 24, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
5,500$3.79$20.8K40,997Nov 24, 2025Nov 25, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE
Chief Medical Officer
22,000——128,870Oct 9, 2025Oct 10, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
PURCHASE
Chief Medical Officer
22,000$3.79$83.4K57,497Oct 9, 2025Oct 10, 2025 ↗View →
BCAX
BICARA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
22,000$18.45$405.9K35,497Oct 9, 2025Oct 10, 2025 ↗View →
Other insiders · BCAX
Loading peer insiders…
About this filer
CIK 0002034679
ROLE
Chief Medical Officer
PRIMARY
BCAX
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0002034679DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback